Literature DB >> 9048195

Coupled effects of polybrene and calf serum on the efficiency of retroviral transduction and the stability of retroviral vectors.

S Andreadis1, B O Palsson.   

Abstract

The relative concentrations of Polybrene (PB) and calf serum (CS) in retroviral supernatant have considerable effects on the efficiency of retrovirus-mediated gene transfer and the stability of retroviral vectors. The effect of PB on the efficiency of transduction of Moloney murine leukemia virus (MMuLV)-derived vectors is strongly dependent on CS. At a fixed CS concentration, the efficiency of transduction shows a maximum as a function of PB concentration. Increasing the CS concentration shifted this maximum to higher PB concentrations, but the value of the maximum remained the same. Therefore, there were optimal combinations of PB and CS concentrations that maximized the efficiency of gene transfer: 4.4, 8.8, 13.2, and 22 micrograms/ml of PB for 1%, 2.5%, 5%, and 10% (vol/vol) CS, respectively. Moreover, the presence of PB affected significantly the kinetics of retroviral decay. The loss of retroviral activity did not follow simple exponential decay in the absence of PB during the decay period of the viral supernatant. The dynamics of viral inactivation showed an initial phase during which the transduction efficiency remained constant followed by exponential decay. However, in the presence of high PB concentrations (13.2 micrograms/ml) during the decay period of retroviral vectors, the initial delay was lost and the decay was exponential right from the outset. The present results suggest that in addition to virus-cell interactions that occur on the target cell surface, other physico-chemical processes may occur in solution that have profound effect on retroviral activity and therefore they are of particular importance for gene therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048195     DOI: 10.1089/hum.1997.8.3-285

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  9 in total

1.  Optimization of the transductional efficiency of lentiviral vectors: effect of sera and polycations.

Authors:  Warren Denning; Suvendu Das; Siqi Guo; Jun Xu; John C Kappes; Zdenek Hel
Journal:  Mol Biotechnol       Date:  2013-03       Impact factor: 2.695

2.  Insertional mutagenesis of preneoplastic astrocytes by Moloney murine leukemia virus.

Authors:  T A Afanasieva; V Pekarik; M Grazia D'Angelo; M A Klein; T Voigtländer; C Stocking; A Aguzzi
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

3.  Fibrin-mediated lentivirus gene transfer: implications for lentivirus microarrays.

Authors:  Shruti D Raut; Pedro Lei; Roshan M Padmashali; Stelios T Andreadis
Journal:  J Control Release       Date:  2010-02-11       Impact factor: 9.776

4.  Infectious entry by amphotropic as well as ecotropic murine leukemia viruses occurs through an endocytic pathway.

Authors:  L J Katen; M M Januszeski; W F Anderson; K J Hasenkrug; L H Evans
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

Review 5.  Generation of transgenic monkeys with human inherited genetic disease.

Authors:  Anthony W S Chan; Shang-Hsun Yang
Journal:  Methods       Date:  2009-05-23       Impact factor: 3.608

Review 6.  Lentiviral Vector Bioprocessing.

Authors:  Christopher Perry; Andrea C M E Rayat
Journal:  Viruses       Date:  2021-02-09       Impact factor: 5.048

7.  Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies.

Authors:  Maren Soldierer; Arthur Bister; Corinna Haist; Aniththa Thivakaran; Sevgi Can Cengiz; Stephanie Sendker; Nina Bartels; Antonia Thomitzek; Denise Smorra; Maryam Hejazi; Markus Uhrberg; Kathrin Scheckenbach; Cornelia Monzel; Constanze Wiek; Dirk Reinhardt; Naghmeh Niktoreh; Helmut Hanenberg
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

8.  Retroviral and lentiviral vectors for the induction of immunological tolerance.

Authors:  Inès Dufait; Therese Liechtenstein; Alessio Lanna; Christopher Bricogne; Roberta Laranga; Antonella Padella; Karine Breckpot; David Escors
Journal:  Scientifica (Cairo)       Date:  2012-12

Review 9.  The Evolution of Gene Therapy in the Treatment of Metabolic Liver Diseases.

Authors:  Carlos G Moscoso; Clifford J Steer
Journal:  Genes (Basel)       Date:  2020-08-10       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.